Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (191-200 of 991) with videos related to

Pageof 100
Sort By:
Contributions to Nephrology|September 7, 2011
Endothelin antagonism in patients with resistant hypertension and hypertension nephropathyIvana Lazich, George L Bakris
Cardiovascular Drugs and Therapy|August 10, 2000
Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockersS Koshy, G L Bakris
Journal of Clinical Pharmacology|May 1, 1993
Renal effects of antihypertensive medications: an overviewK C Abbott, G Bakris
American Journal of Nephrology|November 14, 2018
Intradialytic Hypotension: Is Midodrine the Answer?Mary Hammes, George L Bakris
Nature Reviews. Endocrinology|October 1, 2016
Diabetes: Blood pressure goals in T2DM - time for a rethink?Farheen K Dojki, George Bakris
Current Opinion in Nephrology and Hypertension|July 24, 2012
Approaches for targeting blood pressure control in sleep disordersAmy Guralnick, George L Bakris
Current Hypertension Reports|July 27, 2012
Timing and efficacy of alternative methods of sympathetic blockadeAlexandros Briasoulis, George L Bakris
European Journal of Pharmacology|July 24, 2024
A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An updateOlivia Blazek, George L Bakris
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
Socioeconomic impact of diabetic nephropathy: can we improve the outcome?G Simeon, G L Bakris
Polskie Archiwum Medycyny Wewnetrznej|December 8, 2007
Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trialIrena Duka, George L Bakris
Pageof 100

Showing results (191-200 of 991) with videos related to

Sort By:
Pageof 100
Contributions to Nephrology|September 7, 2011
Endothelin antagonism in patients with resistant hypertension and hypertension nephropathyIvana Lazich, George L Bakris
Cardiovascular Drugs and Therapy|August 10, 2000
Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockersS Koshy, G L Bakris
Journal of Clinical Pharmacology|May 1, 1993
Renal effects of antihypertensive medications: an overviewK C Abbott, G Bakris
American Journal of Nephrology|November 14, 2018
Intradialytic Hypotension: Is Midodrine the Answer?Mary Hammes, George L Bakris
Nature Reviews. Endocrinology|October 1, 2016
Diabetes: Blood pressure goals in T2DM - time for a rethink?Farheen K Dojki, George Bakris
Current Opinion in Nephrology and Hypertension|July 24, 2012
Approaches for targeting blood pressure control in sleep disordersAmy Guralnick, George L Bakris
Current Hypertension Reports|July 27, 2012
Timing and efficacy of alternative methods of sympathetic blockadeAlexandros Briasoulis, George L Bakris
European Journal of Pharmacology|July 24, 2024
A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An updateOlivia Blazek, George L Bakris
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
Socioeconomic impact of diabetic nephropathy: can we improve the outcome?G Simeon, G L Bakris
Polskie Archiwum Medycyny Wewnetrznej|December 8, 2007
Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trialIrena Duka, George L Bakris
Pageof 100